Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03402802 · ClinicalTrials.gov registry record

Steroid Eyedrop Adherence After Trabeculectomy

A clinical trial of Glaucoma and Adherence, Patient, sponsored by Johns Hopkins University.

Completed
Registry status
92
Enrollment target
1
Study location

NCT03402802: Completed study of Glaucoma and Adherence, Patient, sponsored by Johns Hopkins University.

NCT03402802 is a study of Glaucoma and Adherence, Patient that has completed, run by Johns Hopkins University. The registered enrollment target is 92 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03402802, a study of Glaucoma and Adherence, Patient, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
92 participants
Enrollment target
1
Study location

Study Summary

The study will monitor how often persons use eye drops that are prescribed after glaucoma surgery and will compare the adherence with drop use to the success rate of the surgery.

Interventions

  • DRUG monitoring of adherence with medication

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2019-09-01
Est. Completion 2021-08-25

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03402802

The ClinicalTrials.gov registry entry for NCT03402802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which monitoring of adherence with medication is the first listed.

NCT03402802 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03402802 about?

NCT03402802 is a clinical study titled "Steroid Eyedrop Adherence After Trabeculectomy". The study will monitor how often persons use eye drops that are prescribed after glaucoma surgery and will compare the adherence with drop use to the success rate of the surgery.

What is the current status of trial NCT03402802?

This trial is currently completed. The enrollment target is 92 participants. The study started on 2019-09-01. Estimated completion is 2021-08-25.

What conditions does trial NCT03402802 study?

This clinical trial studies the following conditions: Glaucoma, Adherence, Patient.

What interventions are being tested in trial NCT03402802?

The interventions under investigation include: monitoring of adherence with medication (DRUG).

Who is sponsoring clinical trial NCT03402802?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03402802 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.